Skip to content

The investigation of the 50% effective dose of dexmedetomidine in general anesthesia induction for abdominal surgery

The investigation of the 50% effective dose of dexmedetomidine in general anesthesia induction for abdominal surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055246
Enrollment
Unknown
Registered
2022-01-04
Start date
2022-01-07
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Experimental group:Anesthesia induction of dexmedetomidine

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. ASA I-II level; 3. Elective abdominal surgery.

Exclusion criteria

Exclusion criteria: 1. Anemia, hemoglobin 30kg/m^2; 2. Sinus bradycardia (HR<50bpm) or high-grade heart block (II degree 2 or III degree), cardiac insufficiency, LVEF<50%, liver and kidney insufficiency; 3. Systemic or vital organ infection; 4. Long-term use of a-receptor blockers to lower blood pressure, long-term use of psychotropic drugs, antiepileptic drugs or analgesics; 5. Conversion to laparotomy, or intraoperative bleeding that requires blood transfusion; 6. Alcoholism; 7. Have a history of allergy to the anesthetics used in this study.

Design outcomes

Primary

MeasureTime frame
The ED50 of dexmedetomidine for induction of genaral anesthesia;

Secondary

MeasureTime frame
Heart rate during the induction period;Blood pressure during the induction period;The depth of anesthesia during anesthesia induction;Induction time;

Countries

China

Contacts

Public ContactNi Cheng

Cancer Hospital, Chinese Academy of Medical Sciences

nicheng83@163.com+86 13681569807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026